{
    "index":413,
    "text":"'drug makers use co pay coupons help mask rising drug prices drug maker funded coupons patient assistance programs proving uncertain often questionable way patients afford new report shows increasingly expensive specialty brand name drugs growth drug spending commercial government insurance plans slowed last year less half growth rate report quintilesims institute showed much slowing due lower sales hepatitis c drugs still report wednesday blue cross blue shield association bcbsa found cumulative spending drugs still patent rising average annual rate double rate increase spending drugs period overall spending brand name generic drugs competition dropped analysis million bsbsa commercial insurance claims showed underscoring needs coupons patients account prescriptions responsible total pocket costs quintilesims report shows patients advocates say co pay assistance enhances drug maker public image obscures high prices one patient advocate says companies often write assistance taxes gives another financial benefit new quintilesims report found percentage prescriptions filled using coupon increased become little bit war health plans pharmaceutical manufacturers says murray aitken executive director quintilesims institute limiting patients pocket costs drugs drug companies thwart effective tool insurers control drug costs commercially insured patients meet deductibles pocket premiums insurers pay higher drug costs get passed along higher premiums medicare patients prohibited using co pay coupons often eligible drug makers patient assistance programs higher co pay supposed make wonder really want drug says salisbury md pharmacist matthew balish one balishs customers however says really appreciates xarelto zero co pay card starlin weaver science education professor salisbury state university takes blood thinner prevent blood clots like one nearly killed tried competing drugs insurer agreed pay xarelto says work well ill pay whatever pay weaver says doctor told xarelto drug likely prevent another clot coupons match price hikes widespread public outcry high epipen prices last summer co pay coupons offset huge price hikes especially high deductible insurance plans reductions level drug maker assistance driving home pricey patients drugs far broader swath patients half commercially insured patients pocket spending brand medicines based full list price rather discounted price insurer pharmacist pays according analysis amundsen consulting commissioned pharmaceutical research manufacturers america phrma co pay coupons help offset says phrma spokeswoman holly campbell drug makers use marketing budgets pay co pay coupons patient assistance medicare patients prohibited fro using coupons comes directly drug companies foundations outside charities multiple myeloma patient david mitchell founded group patients affordable drugs february decries drug makers ability get tax deductions something bill charity really marketing money largely returned coffers say help patients says mitchell know market share much come back drug know every penny coming back balish agrees shame drug makers price products exorbitantly must offer assistance programs form charity prices continue rise coupons patient assistance affect patients different ways donut hole medicare patients seldom realize often hefty help getting drug companies counts contribution means hit coverage gap known donut hole faster says phoenix pharmacist teresa stickler patients high priced cholesterol drugs including repatha praluent simply stop taking medications cost sharing goes hit medicares catastrophic coverage point spent pocket cost sharing covered drugs drops significantly rest year co pay card changes drug maker janssen pharmaceuticals makes xarelto changed co pay card policy early year patients zero co pay set year customers often shocked learn co pay assistance went away one balishs customers retiree shocked find suddenly owed month xarelto nothing limited assistance new patient assistance funds become available different drugs pharmacists patient groups say alert customers many lose high demand close two three days says tim coetzee chief research officer national multiple sclerosis society speaks broader issue deal economics view medications need affordable accessible system get quarter people taking either brand name specialty drugs simply stop taking deductible meet according new quintiles ims report deductibles rate abandonment prescriptions higher specialty drugs compared brand name drugs got abandoned drug stores time among bcbsas top patent protected drugs spending multiple sclerosis ms drug gilenya increased seven year period price increases led ms patients national ms society critical drug pricing patient assistance financial assistance industry amounts dirty infected band aid problem high drug prices ms blogger author trevis gleason wrote recently three ms drugs market gleason diagnosed ms years ago newer expensive drug hits markets drug makers raise prices gleason wrote memoir chef interrupted taking disease modifying drug ms currently would cost month read possible solutions include requiring drug makers offer similar co pay assistance patients prohibiting coupons cover length prescription says physician peter bach director memorial sloan kettering cancer centers center health policy outcomes pharmacies report co pay assistance insurers separately patients cash payments bach says would temper price inflation drug makers manipulate market says bach patient pays one way another whether tax dollars medicare higher premiums commercial insurance drugmakers say money co pay assistance unique industry campbell noted emailed statement hospitals providers often charity programs forgive medical bills patients afford cost sharing associated treatment care true says mitchell except pharmaceutical industry uses coupons way clorox incentivize people buy product tell us drug price story healthinsurance usatodaycom '",
    "label":3
}